Editas Medicine Inc. Share Price Today: Live Updates & Key Insights
Editas Medicine Inc. share price today is $2.65, up -4.76%. The stock opened at $2.7525 against the previous close of $2.73, with an intraday high of $2.7525 and low of $2.59.
Editas Medicine Inc. Share Price Chart
Editas Medicine Inc.
Editas Medicine Inc. Share Price Performance
Editas Medicine Inc. Institutional Holdings
Editas Medicine Inc. Market Status
Editas Medicine Inc. Fundamentals
Market Cap 418.95 M
PB Ratio 96.4359
PE Ratio 0.0
Enterprise Value 311.07 M
Total Assets 186.53 M
Volume 1516741
Editas Medicine Inc. Company Financials
About Editas Medicine Inc. & investment objective
Company Information Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. Its lead program is EDIT-401, a one-time therapy designed to reduce LDL cholesterol through the upregulation of the LDL receptor to treat hyperlipidemia. The company also develops therapies to treat Sickle cell disease and transfusion-dependent beta thalassemia; and in vivo gene editing medicines indicated for other cells and tissues. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors, and autoimmune disease. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.
Organisation Biotechnology
Employees 87
Industry Biotechnology
CEO Dr. Gilmore O'Neill M.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Editas Medicine Inc. FAQs
What is the share price of Editas Medicine Inc. today?
The current share price of Editas Medicine Inc. is $2.65.
Can I buy Editas Medicine Inc. shares in India?
Yes, Indian investors can buy Editas Medicine Inc. shares by opening an international trading and demat account with Motilal Oswal.
How to buy Editas Medicine Inc. shares in India?
You can easily invest in Editas Medicine Inc. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Editas Medicine Inc. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Editas Medicine Inc..
Can I buy fractional shares of Editas Medicine Inc.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Editas Medicine Inc.?
Editas Medicine Inc. has a market cap of $418.95 M.
In which sector does Editas Medicine Inc. belong?
Editas Medicine Inc. operates in the Biotechnology sector.
What documents are required to invest in Editas Medicine Inc. stocks?
To invest, you typically need:
What is the PE and PB ratio of Editas Medicine Inc.?
The PE ratio of Editas Medicine Inc. is N/A and the PB ratio is 96.44.